Experts Achieve Consensus on a Majority of Statements Regarding Platelet-Rich Plasma Treatments for Treatment of Musculoskeletal Pathology
2023; Elsevier BV; Volume: 40; Issue: 2 Linguagem: Inglês
10.1016/j.arthro.2023.08.020
ISSN1526-3231
AutoresEoghan T. Hurley, Seth L. Sherman, Daniel J. Stokes, Scott A. Rodeo, Shane A. Shapiro, Kenneth Mautner, Don Buford, Jason L. Dragoo, Bert R. Mandelbaum, Kenneth R. Zaslav, Brian J. Cole, Rachel M. Frank, Mukesh Ahuja, Adam W. Anz, Jorge Chahla, Constance R. Chu, Ramón Cugat, João Espregueira‐Mendes, Jack Farr, David C. Flanigan, Alberto Gobbi, Andreas H. Gomoll, Daniel A. Grande, Mederic M. Hall, Kay Horsch, Jason L. Koh, Elizaveta Kon, Christian Lattermann, Louis F. McIntyre, Iain R. Murray, George F. Muschler, Norimasa Nakamura, Surena Namdari, Nicolás S. Piuzzi, Daniël B.F. Saris, Nicholas A. Sgaglione, Kurt P. Spindler, John M. Tokish, Adam B. Yanke,
Tópico(s)Genital Health and Disease
ResumoTo establish consensus statements on platelet-rich plasma (PRP) for the treatment of musculoskeletal pathologies.
Referência(s)